Biotech stock GeneDx broke out after the FDA issued its first AI rules for medical devices. Globus Medical and GeneDx are in buy zones.

The post Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector appeared first on Investor’s Business Daily.